NASDAQ:ACST

Delisted

Acasti Pharma Stock News

Healthcare > Biotechnology

Buy ACST

*Your capital is at risk

$3.37

+0 (+0%)

At Close: Jan 24, 2025

19 Healthcare Stocks Moving In Thursday's Pre-Market Session

12:00am, Thursday, 14'th Nov 2019

Acasti Pharma Q2 EPS $(0.34) Misses $(0.16) Estimate

12:00am, Wednesday, 13'th Nov 2019

Acasti Pharma shares are trading higher despite no company-specific news. The stock is trading on higher-than-average volume.

12:00am, Tuesday, 12'th Nov 2019

Acasti Pharma Reports Partnership With Aker BioMarine To Deliver Krill Oil To Co. Under 2-Year Deal, No Terms Disclosed

12:00am, Monday, 04'th Nov 2019

28 Healthcare Stocks Moving In Friday's Pre-Market Session

12:00am, Friday, 11'th Oct 2019

Acasti Pharma And Amarin In Severe Hypertriglyceridemia

12:00am, Thursday, 10'th Oct 2019

Acasti Pharma (ACST) Investor Presentation - Slideshow

12:00am, Thursday, 03'rd Oct 2019

25 Healthcare Stocks Moving In Wednesday's Pre-Market Session

12:00am, Wednesday, 02'nd Oct 2019

Acasti Pharma Announces Phase 3 Milestones Achieved

12:00am, Monday, 30'th Sep 2019

23 Healthcare Stocks Moving In Wednesday's Pre-Market Session

12:00am, Wednesday, 25'th Sep 2019

Acasti Pharma (ACST) Investor Presentation - Slideshow

12:00am, Wednesday, 18'th Sep 2019

Acasti Pharma Receives Funding From The Government Of Canada To Expand Production Capacity

12:00am, Monday, 09'th Sep 2019

UPDATE: B. Riley FBR On Acasti Pharma Also Notes 'CaPre could be the best-in-class omega-3 fatty acid drug and could capture a large share of the market, even without a first-to-market advantage. We project >C$100M in sales revenue in FY24'

12:00am, Thursday, 29'th Aug 2019

Acasti Pharma Stock News

19 Healthcare Stocks Moving In Thursday's Pre-Market Session

Acasti Pharma Q2 EPS $(0.34) Misses $(0.16) Estimate

Acasti Pharma shares are trading higher despite no company-specific news. The stock is trading on higher-than-average volume.

Acasti Pharma Reports Partnership With Aker BioMarine To Deliver Krill Oil To Co. Under 2-Year Deal, No Terms Disclosed

28 Healthcare Stocks Moving In Friday's Pre-Market Session

Acasti Pharma And Amarin In Severe Hypertriglyceridemia

Acasti Pharma (ACST) Investor Presentation - Slideshow

25 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Acasti Pharma Announces Phase 3 Milestones Achieved

23 Healthcare Stocks Moving In Wednesday's Pre-Market Session

Acasti Pharma (ACST) Investor Presentation - Slideshow

Acasti Pharma Receives Funding From The Government Of Canada To Expand Production Capacity

UPDATE: B. Riley FBR On Acasti Pharma Also Notes 'CaPre could be the best-in-class omega-3 fatty acid drug and could capture a large share of the market, even without a first-to-market advantage. We project >C$100M in sales revenue in FY24'

Acasti Pharma Announces the Election of Its Directors, Amendments to Its Stock Option and ...

22 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Top Fintech Company